標題: Titlebook: Cutaneous Biometrics; Howard Maibach,Nily Osman Book 2024Latest edition Springer Nature Switzerland AG 2024 clinical relevance percutaneou [打印本頁] 作者: 揭發(fā) 時間: 2025-3-21 17:04
書目名稱Cutaneous Biometrics影響因子(影響力)
書目名稱Cutaneous Biometrics影響因子(影響力)學科排名
書目名稱Cutaneous Biometrics網(wǎng)絡公開度
書目名稱Cutaneous Biometrics網(wǎng)絡公開度學科排名
書目名稱Cutaneous Biometrics被引頻次
書目名稱Cutaneous Biometrics被引頻次學科排名
書目名稱Cutaneous Biometrics年度引用
書目名稱Cutaneous Biometrics年度引用學科排名
書目名稱Cutaneous Biometrics讀者反饋
書目名稱Cutaneous Biometrics讀者反饋學科排名
作者: 諷刺 時間: 2025-3-21 20:13
nce of creating meaningful dermatological patient outcome me.This handbook covers the essential subject areas of cutaneous biometrics, including acne, aging, genetics, eczema, psoriasis, atopic dermatitis, rosacea, wound healing, and more. Erythema of rosacea and the risk of skin ulceration associat作者: 神化怪物 時間: 2025-3-22 01:39 作者: extinguish 時間: 2025-3-22 08:27 作者: consolidate 時間: 2025-3-22 11:07
Yosuke Nagaoka,Hidetoshi Fukuyamaidermis from the dermis. At the same time, fluid accumulates leading to macroscopically visible blisters. The time to blister development depends on a number of intrinsic, systemic, and local factors, and it is a direct indicator of the dermoepidermal adhesion strength. Therefore, this parameter plays a role in skin research.作者: contradict 時間: 2025-3-22 13:57 作者: contradict 時間: 2025-3-22 19:32
https://doi.org/10.1007/978-3-642-47430-9extremely limited and comprises of small RCTs, case series, and case studies. Newer and emerging treatments including antitumor necrosis factor agents, intravenous immunoglobulin, and rituximab appear to be promising interventions. More research should be conducted to evaluate the efficacy of these treatments.作者: Parabola 時間: 2025-3-23 01:01
https://doi.org/10.1007/978-1-349-11996-7the Physician Global Assessment, and the Cutaneous Assessment Tool-Binary Method. Based on validation studies outlined in this chapter, it appears that the Cutaneous Dermatomyositis Disease Area and Severity Index demonstrates superiority over the other tools and is a useful outcome measure for dermatomyositis.作者: septicemia 時間: 2025-3-23 05:02 作者: 統(tǒng)治人類 時間: 2025-3-23 06:55
Pemphigus Vulgaris: An Evidence-Based Treatment Update,extremely limited and comprises of small RCTs, case series, and case studies. Newer and emerging treatments including antitumor necrosis factor agents, intravenous immunoglobulin, and rituximab appear to be promising interventions. More research should be conducted to evaluate the efficacy of these treatments.作者: deficiency 時間: 2025-3-23 11:16 作者: 觀察 時間: 2025-3-23 17:34
Dermoepidermal Adhesion Strength Measurement Using Suction Blisters,idermis from the dermis. At the same time, fluid accumulates leading to macroscopically visible blisters. The time to blister development depends on a number of intrinsic, systemic, and local factors, and it is a direct indicator of the dermoepidermal adhesion strength. Therefore, this parameter plays a role in skin research.作者: Aphorism 時間: 2025-3-23 18:26
Rosacea Severity Assessment: Review of Evaluation Methods Used in Clinical Trials,erity assessment is most commonly measured specifically through changes in facial erythema, followed by papules and pustular count and then telangiectasia. Visual inspection by a clinician is the most common modality of assessment of erythema, with a four-point scale as the most frequent methodology作者: 菊花 時間: 2025-3-24 01:30
Pemphigus Disease Activity Measurements: Pemphigus Disease Area Index, Autoimmune Bullous Skin Disoresponsiveness. Here, PDAI, ABSIS, and PVAS are presented and compared based on their measurement properties including reliability, feasibility, and correlation with anti-desmoglein?levels using one large prospective study (n?=?100) comparing all three measures. Additionally, a review of additional 作者: 勛章 時間: 2025-3-24 05:39 作者: 微粒 時間: 2025-3-24 10:34
Transcriptional Profiling Use to Improve Personalized Diagnosis and Management of Cutaneous T-Cell re upregulated in progressive disease, consistent with the notion of malignant inflammation in a pro-tumorigenic microenvironment. Furthermore, over 200 genes with known association with CTCL pathogenesis have been individually tested by RT-PCR, revealing a panel of 17 genes that can distinguish CTC作者: 赦免 時間: 2025-3-24 12:29
Cutaneous Sarcoidosis Outcome Instruments: Reliability and Validity Among Dermatologists, Pulmonolols. Both of these instruments demonstrated markedly decreased reliability when tested using store-and-forward teledermatology technology. High-frequency ultrasonography (HFU) is an emerging technology that could provide a valid, reliable, and objective measure of cutaneous sarcoidosis activity. Furt作者: essential-fats 時間: 2025-3-24 18:23
Atopic Dermatitis Outcome Measures,ndex (DLQI) being two of the more preferred measures for eczema clinical trials, although the better of the two is yet to be decided by consensus. HOME is also making progress toward defining the core outcome measure for the long-term control domain, with future consensus meetings planned.作者: PATRI 時間: 2025-3-24 22:10 作者: 吸氣 時間: 2025-3-24 23:48
Book 2024Latest editions biometrics and how it can be applied to their work...This book also:?..Broadens reader‘s understanding of the importance of creating meaningful dermatological patient outcome measurements and the use of the physician global assessment in a clinical setting to measure and track patient outcomes..?.作者: ethereal 時間: 2025-3-25 04:41 作者: 角斗士 時間: 2025-3-25 11:05
https://doi.org/10.1007/978-3-642-47430-9responsiveness. Here, PDAI, ABSIS, and PVAS are presented and compared based on their measurement properties including reliability, feasibility, and correlation with anti-desmoglein?levels using one large prospective study (n?=?100) comparing all three measures. Additionally, a review of additional 作者: hermitage 時間: 2025-3-25 14:10 作者: Condense 時間: 2025-3-25 19:32 作者: 輕彈 時間: 2025-3-25 20:42 作者: 開始從未 時間: 2025-3-26 00:40 作者: PRO 時間: 2025-3-26 07:02 作者: TSH582 時間: 2025-3-26 11:02
Yosuke Nagaoka,Hidetoshi Fukuyama erythema or phyma or two of the major criteria, which include flushing, papules/pustules, telangiectasia, and ocular manifestations. Assessment of facial erythema is of importance given its prevalence as the most common diagnostic feature of rosacea. Both physician-reported and patient-reported mea作者: tenuous 時間: 2025-3-26 16:08 作者: 修改 時間: 2025-3-26 19:38 作者: 屈尊 時間: 2025-3-26 21:43
https://doi.org/10.1007/978-3-642-47430-9tes long-term aggressive treatment, for which systemic corticosteroid is the gold standard. However, the serious complications associated with systemic corticosteroids have led to the development of various adjuvant therapies including azathioprine, mycophenolate mofetil, methotrexate, cyclophospham作者: 誘騙 時間: 2025-3-27 04:18
https://doi.org/10.1007/978-3-476-04048-0d past damage from AIBD can cause significant morbidity and negatively impact on the patient’s function. It is therefore important that the outcome measures of AIBD used in practice are objective, reliable, and specific. The development and validation of outcome measures specific to AIBD have been a作者: Lignans 時間: 2025-3-27 07:11
The Steamroller and the Violin,ilitate clinical management and research, an accurate and practical method of assessing acne severity is required. Over the years, a myriad of acne global grading scales (AGGSs) have been developed. However, the lack of agreement regarding elements required for an AGGS has prevented the institution 作者: 追蹤 時間: 2025-3-27 13:11 作者: 窒息 時間: 2025-3-27 17:04
https://doi.org/10.1007/978-1-349-11996-7ife and are difficult to treat. Therefore, clinical trials for effective therapies to treat the skin involvement in dermatomyositis are critical. There are many validated outcome measures that allow physicians to objectively evaluate response to treatment in clinical trials and in the clinic. This c作者: Conquest 時間: 2025-3-27 18:58 作者: 精密 時間: 2025-3-28 01:12
Das Wasserstoffbombenprojekt im FIAN the Harmonizing Outcome Measures for Eczema (HOME) initiative. Clinical signs, symptoms, quality of life, and long-term control have been defined by the HOME group as the core outcome domains to be used as primary or secondary endpoints for atopic dermatitis trials. The Eczema Area and Severity Ind作者: 壯麗的去 時間: 2025-3-28 02:11 作者: Solace 時間: 2025-3-28 09:43 作者: 一加就噴出 時間: 2025-3-28 11:24 作者: Vo2-Max 時間: 2025-3-28 16:16 作者: 裂口 時間: 2025-3-28 19:11
Rosacea Severity Assessment: Review of Evaluation Methods Used in Clinical Trials,atient satisfaction and clinical results. Clinical trials have been executed to provide evidence-based support for the efficacy of novel rosacea treatment options. The current assessment tools used to classify the severity of rosacea in clinical trials are not standardized, limiting our ability to c作者: 哺乳動物 時間: 2025-3-28 23:53
Facial Erythema of Rosacea: Grading Scales, erythema or phyma or two of the major criteria, which include flushing, papules/pustules, telangiectasia, and ocular manifestations. Assessment of facial erythema is of importance given its prevalence as the most common diagnostic feature of rosacea. Both physician-reported and patient-reported mea作者: 乳白光 時間: 2025-3-29 03:11
Dermoepidermal Adhesion Strength Measurement Using Suction Blisters,ermal adhesion may lead to cutaneous fragility, lesions, and wounds. Suction blisters develop, when a prolonged constant negative pressure is applied on a defined area of the skin surface. During continuous suction, hemidesmosomes detach from the basement membrane leading to the separation of the ep作者: AXIS 時間: 2025-3-29 09:37 作者: 不舒服 時間: 2025-3-29 13:12
Pemphigus Vulgaris: An Evidence-Based Treatment Update,tes long-term aggressive treatment, for which systemic corticosteroid is the gold standard. However, the serious complications associated with systemic corticosteroids have led to the development of various adjuvant therapies including azathioprine, mycophenolate mofetil, methotrexate, cyclophospham作者: strdulate 時間: 2025-3-29 18:53
Autoimmune Blistering Disease: Outcome Measures,d past damage from AIBD can cause significant morbidity and negatively impact on the patient’s function. It is therefore important that the outcome measures of AIBD used in practice are objective, reliable, and specific. The development and validation of outcome measures specific to AIBD have been a作者: 引水渠 時間: 2025-3-29 23:20
Acne Severity Grading: Determining Essential Clinical Component and Features,ilitate clinical management and research, an accurate and practical method of assessing acne severity is required. Over the years, a myriad of acne global grading scales (AGGSs) have been developed. However, the lack of agreement regarding elements required for an AGGS has prevented the institution
